H. Blythman

992 total citations
16 papers, 686 citations indexed

About

H. Blythman is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, H. Blythman has authored 16 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Biotechnology and 4 papers in Molecular Biology. Recurrent topics in H. Blythman's work include Toxin Mechanisms and Immunotoxins (10 papers), Transgenic Plants and Applications (5 papers) and Glycosylation and Glycoproteins Research (2 papers). H. Blythman is often cited by papers focused on Toxin Mechanisms and Immunotoxins (10 papers), Transgenic Plants and Applications (5 papers) and Glycosylation and Glycoproteins Research (2 papers). H. Blythman collaborates with scholars based in France, United States and Switzerland. H. Blythman's co-authors include Pierre Casellas, F. K. Jansen, Pierre Gros, Hubert Vidal, F Paolucci, Bernard Pau, Olivier Gros, Byron H. Waksman, Bernard Bourrié and Howard Ozer and has published in prestigious journals such as Nature, The Journal of Immunology and PLoS ONE.

In The Last Decade

H. Blythman

16 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Blythman France	11	502	333	261	210	69	16	686
Jeffrey A. Heinbaugh United States	8	602 1.2×	30 0.1×	182 0.7×	112 0.5×	111 1.6×	10	837
Joan E. Smallshaw United States	14	549 1.1×	463 1.4×	239 0.9×	114 0.5×	52 0.8×	21	689
Ferdynand J. Kos United States	11	439 0.9×	84 0.3×	193 0.7×	23 0.1×	74 1.1×	16	651
Pamela H. Gulden United States	8	899 1.8×	49 0.1×	480 1.8×	104 0.5×	301 4.4×	9	1.1k
Angelyn Rios United States	15	320 0.6×	163 0.5×	231 0.9×	52 0.2×	120 1.7×	24	580
Andreas Lingnau Germany	15	124 0.2×	304 0.9×	244 0.9×	76 0.4×	138 2.0×	23	803
G D Bonnard United States	12	475 0.9×	37 0.1×	134 0.5×	115 0.5×	119 1.7×	18	721
J M Decker United States	13	331 0.7×	21 0.1×	319 1.2×	74 0.4×	31 0.4×	19	632
Matt Devalaraja United States	5	141 0.3×	47 0.1×	206 0.8×	45 0.2×	99 1.4×	6	393
Laura Kruijssen Netherlands	12	348 0.7×	41 0.1×	353 1.4×	48 0.2×	144 2.1×	21	640

Countries citing papers authored by H. Blythman

Since Specialization

Citations

This map shows the geographic impact of H. Blythman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Blythman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Blythman more than expected).

Fields of papers citing papers by H. Blythman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Blythman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Blythman. The network helps show where H. Blythman may publish in the future.

Co-authorship network of co-authors of H. Blythman

This figure shows the co-authorship network connecting the top 25 collaborators of H. Blythman. A scholar is included among the top collaborators of H. Blythman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Blythman. H. Blythman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Audran, R, Blaise Genton, H. Blythman, et al.. (2009). The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial. PLoS ONE. 4(10). e7304–e7304. 17 indexed citations

Stahel, R., H. Lacroix, Sculier Jp, et al.. (1992). Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer. Annals of Oncology. 3(4). 319–320. 18 indexed citations

Antin, Joseph H., Barbara E. Bierer, B R Smith, et al.. (1990). Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.. PubMed. 333. 207–15. 6 indexed citations

Hertler, Andrew, David M. Schlossman, Michael J. Borowitz, et al.. (1989). An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin. International Journal of Cancer. 43(2). 215–219. 54 indexed citations

Griffin, Thomas W., A C Morgan, & H. Blythman. (1988). Immunotoxin therapy: Assessment by animal models. Cancer treatment and research. 37. 433–455. 10 indexed citations

Bourrié, Bernard, Pierre Casellas, H. Blythman, & F. K. Jansen. (1986). Study of the plasma clearance of antibody – ricin‐A‐chain immunotoxins. European Journal of Biochemistry. 155(1). 1–10. 100 indexed citations

Blythman, H., et al.. (1986). Immunotoxins as tools for the study and treatment of a mouse lymphoma. Leukemia Research. 10(7). 871–871. 2 indexed citations

Blythman, H., Pierre Casellas, G Laurent, & F. K. Jansen. (1985). Recent advances with immunotoxins. European Journal of Cancer and Clinical Oncology. 21(11). 1373–1373. 4 indexed citations

Colombatti, Marco, Alfonso Colombatti, H. Blythman, & Camille Bron. (1984). Thy 1.2<sup>+</sup> Leukemia Cells Eradicated From In Vitro Leukemia-Bone Marrow Cell Mixtures by Antibody-Toxin Conjugates<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 72(5). 1095–9. 9 indexed citations

10.

Jansen, F. K., H. Blythman, Dominique Carrière, et al.. (1982). Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity. Immunological Reviews. 62(1). 185–216. 136 indexed citations

11.

Blythman, H., Pierre Casellas, Olivier Gros, et al.. (1981). Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature. 290(5802). 145–146. 192 indexed citations

12.

Jansen, F. K., H. Blythman, Dominique Carrière, et al.. (1980). High specific cytotoxicity of antibody-toxin hybrid molecules (immunotoxins) for target cells. Immunology Letters. 2(2). 97–102. 40 indexed citations

13.

Blythman, H. & Rosemary G. White. (1977). Effect of early bursectomy on germinal centre and immunoglobulin production in chickens.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(5). 671–7. 14 indexed citations

14.

Blythman, H. & Byron H. Waksman. (1973). Effect of Irradiation and Appendicostomy on Appendix Structure and Responses of Appendix Cells to Mitogens. The Journal of Immunology. 111(1). 171–182. 17 indexed citations

15.

Waksman, Byron H., Howard Ozer, & H. Blythman. (1973). Appendix and M-antibody formation. VI. The functional anatomy of the rabbit appendix.. PubMed. 28(5). 614–26. 61 indexed citations

16.

Blythman, H. & Byron H. Waksman. (1973). Effect of Locally Administered Endotoxin on Regenerating Appendix Structure and Responses of Appendix Cells to Mitogens. The Journal of Immunology. 111(4). 1081–1085. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact